Literature DB >> 8287521

Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods.

C W Weykamp1, T J Penders, F A Muskiet, W van der Slik.   

Abstract

One hundred eleven laboratories, using 21 different methods based on five different principles, determined glycohemoglobin (GHb) percentages in two identical series of six lyophilized hemolysates and three similarly processed calibrators, distributed 3 months apart. To assign GHb percentages to calibrators, we used HbA1c results from nine participants who used the Bio-Rad Diamat high-performance liquid chromatographic method. Three-point calibration with assigned values improved mean intralaboratory variation (CV) from 6.6% to 3.5%. For samples with low (5.5%) and high (14.1%) GHb percentages, respectively, calibration decreased interlaboratory variation per method (from 10% to 4% and from 6% to 3%), inter-method variation (from 18% to 4% and from 16% to 3%), and overall interlaboratory variation (from 25% to 7% and from 15% to 4%). Without calibration, 71% of the laboratories did not meet the clinically desirable intralaboratory CV of 3.5%; calibration reduced this proportion to 39%. We conclude that, irrespective of the analytical method used, calibration greatly reduces all sources of GHb variation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8287521

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

2.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.

Authors:  Ian Goodall
Journal:  Clin Biochem Rev       Date:  2005-02

3.  Haemoglobin O Padova and falsely low haemoglobin A1c in a patient with type I diabetes.

Authors:  W J Schnedl; E C Reisinger; S Katzensteiner; R W Lipp; F Schreiber; P Hopmeier; G J Krejs
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

Review 4.  Hemoglobin variants recently detected in Austria.

Authors:  W J Schnedl; E C Reisinger; R W Lipp; G J Krejs; P Hopmeier
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

5.  Long-Term Performance of Point-of-Care Hemoglobin A1c Assays.

Authors:  Sujaytha Paknikar; Rohan Sarmah; Losika Sivaganeshan; Adam Welke; Al Rizzo; Kirk Larson; Marc Rendell
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

Review 6.  Methods, units and quality requirements for the analysis of haemoglobin A1c in diabetes mellitus.

Authors:  Ilkka Penttilä; Karri Penttilä; Päivi Holm; Harri Laitinen; Päivi Ranta; Jukka Törrönen; Rainer Rauramaa
Journal:  World J Methodol       Date:  2016-06-26

7.  Comparative evaluation of three different methods for HbA1c measurement with High-performance liquid chromatography in diabetic patients.

Authors:  Azadeh Karami; Azar Baradaran
Journal:  Adv Biomed Res       Date:  2014-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.